Skip to main content
SpringerLink
Log in

Hypertensive Schwangerschaftserkrankungen

  • Chapter
  • First Online:
Die Geburtshilfe

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Hypertensive Erkrankungen gehören mit ihren verschiedenen klinischen Ausprägungen und Manifestationsarten zu den häufigsten Komplikationen in der Schwangerschaft, und in den industrialisierten Ländern bleibt die Präeklampsie einer der wichtigsten Gründe für die maternale Mortalität. Die meisten Fachgesellschaften fokussieren auf die verschiedenen Hypertoniemanifestationen in der Schwangerschaft als zentrales Kriterium für die Klassifizierung.

Die Prädiktion der Präeklampsie und anderer plazentagebundener Schwangerschaftserkrankungen wurde verfeinert. Die Kombination von Angiogenesefaktoren zusammen mit Anamnese bzw. bestehenden Risikofaktoren, der Dopplersonographie der Aa. uterinae und gewissen klinischen Daten hat die Risikostratifizierung wesentlich verbessert. Nach wie vor ist die einzige kausale Therapie der Präeklampsie die Entbindung. Auch ein Zusammenhang zwischen Präeklampsie und dem späteren Auftreten mütterlicher kardiovaskulärer Erkrankungen gilt als erwiesen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abalos E, Duley L, Steyn D, Henderson-Smart D (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev CD002252

    Google Scholar 

  • Abildgaard U, Heimdal K (2013) Pathogenesis of the hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol 166:117–123

    Article  CAS  PubMed  Google Scholar 

  • ACOG (2001) Practice Bulletin. Chronic hypertension in pregnancy. ACOG committee on practice bulletins. Obstet Gynecol. 98(Suppl 1):177–185

    Google Scholar 

  • ACOG (2002) practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. ACOG committee on practice bulletins-obstetrics. Obstet Gynecol. 99(1):159–167

    Google Scholar 

  • ACOG (2013) Committee opinion 573. Magnesium sulfate use in obstetrics. Obstet Gynecol 122(3):727–728

    Article  Google Scholar 

  • ACOG Comittee Opinion 211 (1998) Anticoagulation with low molecular weight heparin during pregnancy. Washington, DC

    Google Scholar 

  • Ahmad S, Ahmed A (2004) Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 95:884–891

    Article  CAS  PubMed  Google Scholar 

  • Ahmed A (1997) Heparin-binding angiogenic growth factors in pregnancy. Trophoblast Res 10(215):258

    Google Scholar 

  • Ahmed K, Almashhrawi AA, Rahman RN, Hammoud GM, Ibdah JA (2013) Liver diseases in pregnancy: diseases unique to pregnancy. WJG 19:7639–7646

    Article  PubMed  PubMed Central  Google Scholar 

  • Alexander JM, McIntire DD, Levenko KJ, Cunningham FG (2006) Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. Obstet Gynecol 108(4):826–832

    Article  PubMed  Google Scholar 

  • Alkan A, Tugrul S, Oral O, Uslu H, Köse D, Catakli FT (2006) Effects of postpartum uterine curettage on maternal wellbeing in severe preeclamptic patients. Clin Exp Obstet Gynecol 33:55–58

    CAS  PubMed  Google Scholar 

  • Anderson UO, Olsson MG, Ruttardotir S, Centlow M, Kristensen KH, Isberg PE, Thilaganathan B, Akerström B, Hansson SR (2011) Fetal hemoglobin and α1 – macroglobulin as first- and early second-trimester predictive biomarker for preeclampsia. Am J Obstet Gynecol 204:520.e1–520.e5

    Article  CAS  Google Scholar 

  • Ascarelli MH, Johnson V, McCreary H et al (2005) Postpartum preeclampsia management with Furosemid: a randomized clinical trial. Obstet Gynecol 105:29–33

    Article  CAS  PubMed  Google Scholar 

  • Askie LM, Duley L, Henderson-Smart D, Stewart LA, on behalf of the PARIS collabborative group (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798

    Article  CAS  PubMed  Google Scholar 

  • Assali NS, Kaplan S, Oighenstein S, Suyemoto R (1953) Hemodynamic effect of l-hydracinophthalazine in human pregnancy; results of intravensous administration. J Clin Invest 32:922–933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Atkinson MW, Belfort MA, Saade GR, Moise KJ (1994) The relation between magnesium sulfate therapy and fetal heart rate variability. Obstet Gynecol 83:967–970

    Article  CAS  PubMed  Google Scholar 

  • AWMF-Leitlinien-Register Nr.015/018 Diagnostik und Therapie hypertensiver Schwangeschaftserkrankungen. Überarbeitung vom Mai 2008

    Google Scholar 

  • Ayuk PT, Matijevic R (2006) Placental ischaemia is a consquence rather than cause of preeclampsia. Med Hypotheses 67:792–795

    Article  PubMed  Google Scholar 

  • Barron WM, Heckerling P, Hibbard JU, Fisher S (1999) Reducing unneccessary coagulation testing in hypertensive disorders of pregnancy. Obstet Gynecol 94:364–370

    CAS  PubMed  Google Scholar 

  • Barton JR, Sibai BM (1996) Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets count). Am J Obstet Gynecol 174:1820–1825

    Article  CAS  PubMed  Google Scholar 

  • Barton JR, Sibai BM (2008) Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 112:359–372

    Article  PubMed  Google Scholar 

  • Barton JR, O´Brian JM, Bergauer NK et al (2001) Mild gestational hypertension remote from term: progession and outcome. Am J Obstet Gynecol 184:979–983

    Article  CAS  PubMed  Google Scholar 

  • Baschat AA, Gembruch U, Harman CR (2001) The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 18:581–577

    Google Scholar 

  • Bates SM, Greer IA, Papinger I, Shoshana S, Hirsch J (2008) Venous thromboembolism, thrombophila, antithrombotic therapie, and pregnancy. Chest 133:844–886

    Article  CAS  Google Scholar 

  • Baumann MU, Bersinger NA, Surbek DV (2007) Serum markers for predicting pre-eclampsia. Mol Asp Med 28:227–244

    Article  CAS  Google Scholar 

  • Baumann MU, Bersinger NA, Mohaupt MG et al (2008) First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 199:266.e1–266.e6

    Article  CAS  Google Scholar 

  • Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM (2005) Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 192(2):520–521

    Article  CAS  PubMed  Google Scholar 

  • Belfort MA, Moise KJ (1992) Effect of magnesiumsulfate on maternal brain blood flow in preeclampsia: a randomized placebo-controlled study. Am J Obstet Gynecol 167:661–666

    Article  CAS  PubMed  Google Scholar 

  • Belfort MA, Clark SL, Sibai B (2006) Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate. Obstet Gynecol Surv 61:655–665

    Article  PubMed  Google Scholar 

  • Belizan JM, Villar J, Gonzalez L, Campodonica L, Bergel E (1991) Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 325:1399–1405

    Article  CAS  PubMed  Google Scholar 

  • Bellomo G, Narducci PL, Randoni F et al (1999) Prognostic value of 24-hour blood pressure in pregnancy. JAMA 282:1447–1452

    Article  CAS  PubMed  Google Scholar 

  • Bombrys AE, Barton JR, Nowacki EA, Habli M, Pinder L, How H, Sibai BM (2008a) Expectant management of severe preeclampsia at less than 27 weeks’ gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 199:247.e1–247.e6

    Article  Google Scholar 

  • Bombrys AE, Barton JR, Nowacki EA, Habil M, Pinder L, How H et al (2008b) Expectant management odf severe preeclampsia at less than 27 weeks’ gestation. Am J Obstet Gynecol 199:247e1–247e6

    Article  Google Scholar 

  • Bosio PM, McKenna PJ, Conroy R, O´Herlihy C (1999) Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 94:978–984

    CAS  PubMed  Google Scholar 

  • Broekenhuizen FF, Elejalde R, Hamilton RR (1983) Early onset preeclampsia, triploidy and fetal hydrops. J Reprod Med 28:223–226

    Google Scholar 

  • Brown MA, Mangos G, Davis G, Homer C (2005a) The natural history of white coat hypertension during pregnancy. BJOG 112(5):601–606

    Article  PubMed  Google Scholar 

  • Brown MA, Mangos G, Davis G, Homer C (2005b) The natural history of white coat hypertension during pregnancy. BJOG 112(5):601–606

    Article  PubMed  Google Scholar 

  • Bucher HC, Guyatt GH, Cook RJ, Hatala R, Cook DJ, Lang JD, Hunt D (1996) Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized trials. J Am Med Assoc 275:1113–1117

    Article  CAS  Google Scholar 

  • Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S et al (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116(2 Pt 1):402–414

    Article  PubMed  Google Scholar 

  • Burton GJ, Woods AW, Jauniaux E, Kingdom JC (2009) Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30:473–482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Butters L, Kennedy S, Rubin PC (1990) Atenolol in essential hypertension during pregnancy. Br Med J 301:587

    Article  CAS  Google Scholar 

  • Centre for Maternal and Child Enquiries (CMACE) (2011) Saving Mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom. BJOG 118(Suppl 1):1–203

    Google Scholar 

  • Chames MC, Haddad B, Barton RJ et al (2003) Subsequent pregnancy outcome in women with a history of Hellp syndrome at ≤28 weeks of gestation. Am J Obstet Gynecol 188:1504–1507

    Article  PubMed  Google Scholar 

  • Chang EY, Menard MK, Vermillion ST et al (2004) The association between hyaline membrane disease and preeclampsia. Am J Obstet Gynecol 191:1414–1417

    Article  PubMed  Google Scholar 

  • Chappell LC, Duckworth D, Seed PT, Griffin M, Myers J, Mackillop L et al (2013) Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128:2121–2131

    Article  CAS  PubMed  Google Scholar 

  • CLASP (Collaborative low-dose Aspirin study in pregnancy) Collabrative group (1994) CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 105:619–629

    Google Scholar 

  • Cnossen JS, Vollebregt KC, de Virenze N, Riet ter G, Mol BWJ et al (2009) Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia:systemic review and meta-analysis. BMJ 336:1117–1120

    Article  Google Scholar 

  • Cockburn J, Moar VA, Ounsted M, Redman CW (1982) Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1:647–649

    Article  CAS  PubMed  Google Scholar 

  • Cook HW, Briggs JC (1903) Clinical observations on blood pressure. Johns Hopkins Hosp 11:451–455

    Google Scholar 

  • Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Kathi H, Ray WA (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443–2451

    Article  CAS  PubMed  Google Scholar 

  • Coppage KH, Polzin WJ (2002) Severe preeclampsia and delivery outcomes: is immediate cesarean delivery beneficial? Am J Obstet Gynecol 186:921–923

    Article  PubMed  Google Scholar 

  • Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM (2015) Pregnancy-related mortality in the United States, 2006–2010. Obstet Gynecol 125(1):5–12

    Article  PubMed  Google Scholar 

  • Cudmore M, Ahmad S, Al-Ani B et al (2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115:1789–1797

    Article  CAS  PubMed  Google Scholar 

  • Danza A, Ruiz-Irastorza G, Khamashta M (2012) Antiphospholipid syndrome in obstetrics. Best Pract Res Clin Obstet Gynaecol 26:65–76

    Article  PubMed  Google Scholar 

  • Dao V, Rodger M (2009) Anticoagulation to prevent placental-mediated pregnancy complication: a review of current evidence. Curr Opin Hematol 16(5):386–390, 22 [Epub ahead of print]

    Article  CAS  PubMed  Google Scholar 

  • Dashe JS, Ranin SM, Cinningham FG (1998) The long term consequences of thrombotic microangiopathy in pregnancy. Obstet Gynecol 91:662–668

    CAS  PubMed  Google Scholar 

  • Dekker G, Sibai BM (1993) Low dose aspirin in the prevention of preeclampsia and fetal growth retardation: rational mechanisms and clinical trials. Am J Obstet Gynecol 168:214–227

    Article  CAS  PubMed  Google Scholar 

  • Dekker G, Sibai BM (2001) Primary, secondary and tertiary prevention of preeclampsia. Lancet 357:207–215

    Google Scholar 

  • Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C, van Geijn HP (1995) Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 173:1042–1048

    Article  CAS  PubMed  Google Scholar 

  • Derks JB, Mulder EJH, Visser GHA (1995) The effects of maternal bethametasone administration on the fetus. Br J Obstet Gynaecol 102:40–46

    Article  CAS  PubMed  Google Scholar 

  • Deruelle P, Coudoux E, Ego A, Houfflin-Debarge V, Codaccioni X, Subtil D (2006) Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. Eur J Obstet Gynecol Reprod Biol 125(1):59–65

    Article  PubMed  Google Scholar 

  • DGGG, Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (2013). Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. AWMF-Register Nr. 015/018. http://www.awmf.org/leitlinien/detail/ll/015–018.html. Zugegriffen im Dez 2013

  • Douglas KA, Redman CWG (1994) Eclampsia in the United Kingdom. BMJ 309:1395–1400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Duckitt K, Harrington B (2005) Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. Br Med J 330:565

    Article  Google Scholar 

  • Duley L, Henderson-Smart D, Knight M, King J (2004) Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 1, CD004659

    PubMed  Google Scholar 

  • Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D (2010a) Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev (11):CD000025

    Google Scholar 

  • Duley L, Henderson-Smart DJ, Chou D (2010b) Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev (10):CD000025

    Google Scholar 

  • Duley L, Meher S, Johns L (2013) Drugs for treatment of very high blood pressure during pregnancy Cochrane Database Syst Rev 7:CD001449

    Google Scholar 

  • Duvekot JJ, Cheriex EC, Pieters FA, Menheer PP, Peeters LH (1993) Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 169:1382–1392

    Article  CAS  PubMed  Google Scholar 

  • Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 345:1455–1463

    Article  Google Scholar 

  • Facchinetti F, Marozio L, Frusca T et al (2009) Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 200:46.e1–46.e5

    Article  Google Scholar 

  • Fenakel K, Fenakel G, Appelman Z et al (1991) Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 77:331–337

    CAS  PubMed  Google Scholar 

  • Fonseca JF, Mendrez F, Catano C, Arias F (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193:1591–1598

    Article  CAS  PubMed  Google Scholar 

  • Friedman SA, Schiff E, Kaa L, Sibai BM (1995) Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol 172:1785–1792

    Article  CAS  PubMed  Google Scholar 

  • Galarza-Maldonado C, Kourilovitch MR, Pérez-Fernandez OM, Gaybor M, Cordero C et al (2012) Obstetric antiphospholipid syndrome. Autoimmun Rev 11:288–295

    Article  CAS  PubMed  Google Scholar 

  • Gangaram R, Ojwang PJ, Moodley J, Maharaj A (2005) The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy. Hypertens Pregnancy 24:96–101

    Article  CAS  Google Scholar 

  • Genius SJ (2008) A fishy recommendation: omega-3 fatty acid intake in pregnancy. Br J Obstet Gynaecol 115:1–4

    Article  Google Scholar 

  • Gennari-Moser C, Escher G, Kramer S, Dick B, Eisele N, Baumann M, Raio L, Frey FJ, Surbek D, Mohaupt MG (2013) Normotensive blood pressure in pregnancy: the role of salt and aldosterone. Hypertension (2). doi:10.1161

    Google Scholar 

  • Goldenberg RL, Cliver SP, Bronstein J et al (1994) Bed rest in pregnancy. Obstet Gynecol 84:131–136

    CAS  PubMed  Google Scholar 

  • Goldman-Wohl D, Yagel S (2002) Regulation of trophoblast invasion: from normal implantation to preeclampsia. Mol Cell Endocrinol 187:233–238

    Article  CAS  PubMed  Google Scholar 

  • Gray SE, Rodis JF, Lettieri L, Egan JFX, Vintzileos A (1994) Effect of intravenous magnesium sulfate on the biophysical profile in the healthy preterm fetus. Am J Obstet Gynecol 170:1131–1135

    Article  CAS  PubMed  Google Scholar 

  • Greer IA, Walker JJ, McLaren M et al (1985a) A comparative study of the effect of adrenoreceptor antagonist on platelet aggregation and thromboxane generation. Thromb Haemost 54:480–484

    CAS  PubMed  Google Scholar 

  • Greer IA, Walker JJ, McLaren M et al (1985b) Inhibition of thromboxane and prostacyclin in whole blood by adrenoreceptor antagonists. Prostaglandins Leukot Med 19:209–217

    Article  CAS  PubMed  Google Scholar 

  • Gupta AK, Rusterholz C, Huppertz B et al (2005) A comparative study of the effect of three different syncytiotrophoblast micro-particle preparations on endothelial cells. Placenta 26:59–66

    Article  CAS  PubMed  Google Scholar 

  • Hall DR, Odendaal HJ, Steyn DW, Grevé D (2000) Expectant management of early onset, severe preeclampsia maternal outcome. Br J Obstet Gynaecol 107:1252–1257

    Article  CAS  Google Scholar 

  • Hansson SR, Gram M, Akerström B (2013) Fetal hemoglobin in preeclampsia: a new causative factor, a tool for prediction/diagnosis and a potential target for therapy. Curr Opin Obstet Gynecol 25:448–455

    Article  PubMed  Google Scholar 

  • Haram K, Svendson E, Abildgaard U (2009) The hellp syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 9:8

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hauth JC, Ewell MG, Levine RL, Esterlitz JR, Sibai BM, Curet LB (2000) Pregnancy outcomes in health nulliparous women who subsequently developed hypertension: calcium for preeclampsia prevention study group. Obstet Gynecol 95:24–28

    CAS  PubMed  Google Scholar 

  • Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, Senat MV, Visser GHA (2001) Monitoring fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 18:564–570

    Article  CAS  PubMed  Google Scholar 

  • Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I, Williams C, Golding J (2007) Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): a observational cohort study. Lancet 369:578–585

    Article  PubMed  Google Scholar 

  • Higgins JR, de Swiet M (2001) Blood-pressure measurement and classification in pregnancy. Lancet 357:131–135

    Article  CAS  PubMed  Google Scholar 

  • Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, McPherson C et al (2002) Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 186:422–426

    Article  PubMed  Google Scholar 

  • Hoedjes M, Berks D, Vogel I, Franx A et al (2011) Poor health-related quality of life after severe preeclampsia. Birth 38(3):246–255

    Article  PubMed  Google Scholar 

  • Hofmeyer GJ, Duley L, Atallah A (2007) Dietary calcium supplementation for prevention pf pre-eclampsia and related problems: a systemic review and commentary. Br J Obstet Gynaecol 114:933–943

    Article  CAS  Google Scholar 

  • Howie PW, Prentice CRM, Forbes CD (1975) Failure of heparin therapy to affect the clinical course of severe pre-eclampsia. Br J Obstet Gynaecol 82:711–717

    Article  CAS  PubMed  Google Scholar 

  • Hunter SK, Martin M, Benda JA, Zlatnik FJ (1995) Liver transplant after massive spontaneous hepatic rupture in pregnancy complicated by preeclampsia. Obstet Gynecol 85:819–822

    Article  CAS  PubMed  Google Scholar 

  • Huppertz B (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51:970–975

    Article  CAS  PubMed  Google Scholar 

  • Hüskes KP, Baumgartner A, Hardt U, Fink F (1991) Doppelseitige, mehrzeitige Spontanruptur der Leber bei HELLP-Syndrom. Chirurg 62:221–222

    PubMed  Google Scholar 

  • Impey L (1993) Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 100:959–961

    Article  CAS  PubMed  Google Scholar 

  • Inbar O, Blank M, Faden D, Tincani A, Lorber M, Shoenfeld Y (1993) Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin. Am J Obstet Gynecol 169:423–426

    Article  CAS  PubMed  Google Scholar 

  • Innes KE, Marshall JA, Byers TE, Calonge N (1999) A woman's own birth weight and gestational age predict her later risk of developing preeclampsia, a precursor of chronic disease. Epidemiology 10:791–792

    Google Scholar 

  • Jankowicz D, Tuffnell DJ (2004) Managing pre-eclampsia 1: establishing guidelines. Br J Midwifery 12:35–40

    Google Scholar 

  • Jenkins SM, Head BB, Hauth JC (2002) Severe preeclampsia at less than 25 weeks of gestation: maternal and neonatal outcomes. Am J Obstet Gynecol 186:790–795

    Article  PubMed  Google Scholar 

  • Jim B, Sharma S, Kebede T, Acharaya A (2010) Hypertension in pregnancy: a comprehensive update. Cardiol Rev 18(4):178–189

    Article  PubMed  Google Scholar 

  • JNC 7 (2004) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (August 2004). NIH Publication No. 04–5230

    Google Scholar 

  • Jones HMR, Cummings AJ (1978) A sudy of the transfer of alpha-methyldopa to the human fetus and newborn infant. Br J Clin Pharmacol 6:432–434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA (2010) Liver disease in pregnancy. Lancet 375:594–605

    Article  PubMed  Google Scholar 

  • Kahn SR, Platt R, McNamara H et al (2009) Inherited thrombophilia and preeclampsia within a multicenter cohort: the montreal preeclampsia study. Am J Obstet Gynecol 200(2):151.e1–151.e9, discussion e1–5

    Article  Google Scholar 

  • Khalil A, Harrington K, Muttukrishna S, Jauniaux E (2010) Effect of antihypertensive therapy with alpha-methyldopa on uterine artery Doppler in pregnancies with hypertensive disorders. Ultrasound Obstet Gynecol 35:688–694

    CAS  PubMed  Google Scholar 

  • Knight M, Redman CW, Linton EA, Sargent JL (1998) Shedding of syncytrophoblast microvilli into the maternal circulation in preeclamptic pregnancies. Br J Obstet Gynaecol 105:632–640

    Article  CAS  PubMed  Google Scholar 

  • Kuklina EV, Ayala C, Callaghan WM (2009) Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 113(6):1299–1306

    Article  PubMed  Google Scholar 

  • Künzel W, Misselwitz B (2003) Unexpected fetal death during pregnancy – a problem of unrecognized fetal disorders during antenatal care? Eur J Obstet Gynecol Reprod Biol 110(Suppl 1):386–396

    Google Scholar 

  • Kupferminc MJ, Eldor A, Steinman N et al (1999) Increased frequency of genetic thrombophilia. N Engl J Med 340:9–13

    Article  CAS  PubMed  Google Scholar 

  • Kutteh WH (1997) Antiphospholipid antibodies and reproduction. J Reprod Immunol 35:151–171

    Article  CAS  PubMed  Google Scholar 

  • Kweider N, Wruck CJ, Rath W (2013) New insights into the pathogenesis of preeclampsia – the role of Nrf2 activators and their potential therapeutic impact. Geburtshilfe Frauenheilkd 73:1236–1240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lain KJ, Roberts JM (2002) Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287:3183–3186

    Article  PubMed  Google Scholar 

  • Langenveld J, Jansen S, van der Post J, Wolf H et al (2010) Recurrence risk of a delivery before 34 weeks of pregnancy due to an early onset hypertensive disorder: a systemic review. Am J Perinatol 27:565–571

    Article  PubMed  Google Scholar 

  • Lees C, Marlow N, Arabin B, Bilardo CM, TRUFFLE Group et al (2013) Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 42(4):400–408

    Article  CAS  PubMed  Google Scholar 

  • Levine RJ, Maynard SE, Quian C et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683

    Article  CAS  PubMed  Google Scholar 

  • Levine RJ, Thadhaini R, Quian C et al (2005) Urinary placental growth factor and risk of preeclampsia. JAMA 293:77–85

    Article  CAS  PubMed  Google Scholar 

  • Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group (2006) Soluble endoglin and other circulating angiogenic factors in preeclampsia. N Engl J Med 355:992–1005

    Article  CAS  PubMed  Google Scholar 

  • Leviton A, Kuban KC, Pagano M et al (1993) Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns. Pediatrics 91:1083–1088

    CAS  PubMed  Google Scholar 

  • Levytska K, Kingdom J, Bacyk D et al (2013) Heme oxygenase-1 in placental development and pathology. Placenta 34:291–298

    Article  CAS  PubMed  Google Scholar 

  • Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data of 1 million adults in 61 perspective studies. Lancet 360:1903–1913

    Article  PubMed  Google Scholar 

  • Lewis G (Hrsg) (2007) The Confidential enquiry into maternal and child health (CEMACH). Saving mother’s lives: Reviewing maternal deaths to make motherhood safer 2003–2005. The seventh report. RCOG Press, London

    Google Scholar 

  • Li H, Gudnason H, Olofsson P, Dubiel M, Gudmundsson S (2005) Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only one-third of late third-trimester pre-eclamptic women. Ultrasound Obstet Gynecol 25:459–463

    Article  CAS  PubMed  Google Scholar 

  • Liggins GC, Howie RN (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of RDS in premature infants. Pediatrics 50:515–525

    CAS  PubMed  Google Scholar 

  • Lisonkova S, Joseph KS (2013) Incidence pf preeclampsia: risk factors and outcomes associeted with early- versus late-onset disease. Am J Obstet Gynecol 209:544.e1–544.e12

    Article  Google Scholar 

  • Livingston JC, Livingston LW, Ramsey R et al (2003) Magnesium sulfate in women with mild preeclampsia: a randomised controlled trial. Obstet Gynecol 101:217–220

    CAS  PubMed  Google Scholar 

  • Lockwood CJ, Rand JH (1994) The immunbiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 49:432–441

    Article  CAS  PubMed  Google Scholar 

  • Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK et al (2009) Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 49(3):242–246

    Article  PubMed  Google Scholar 

  • Lubarsky SL, Barton JR, Friedman SA, Nasreddine S, Ramadan MK, Sibai BM (1994) Late postpartum eclampsia revisted. Obstet Gynecol 83:502–505

    Article  CAS  PubMed  Google Scholar 

  • Lydakis C, Lip GJ, Beevers M, Beevers BG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12:541–547

    Article  CAS  PubMed  Google Scholar 

  • Mabie WC, Gonzales AR, Sibai BM et al (1987) A comparative trial of labetalol und haydralacine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 70:328–333

    CAS  PubMed  Google Scholar 

  • Magann EF, Martin JN, Isaacs JD, Perry KG, Martin RW, Mey-drech EF (1993) Immediate postpartum curretage: accelerated recovery from severe preeclampsia. Obstet Gynecol 81:502–506

    CAS  PubMed  Google Scholar 

  • Magann EF, Bass D, Chauhan SP, Sullivan DL, Nartin RW, Martin JN (1994a) Disease stabilisation in patients with the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 171:1148–1153

    Article  CAS  PubMed  Google Scholar 

  • Magann EF, Perry KG, Meydrech EF, Harris RL, Chauhan SP, Martin JN (1994b) Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 171:1154–1158

    Article  CAS  PubMed  Google Scholar 

  • Magann EF, Bass D, Chauhan SO (1994c) Accelerated recovery from severe preeclampsia: uterine curettage versus nifedipine. J Soc Gynecol Investig 1:210–214

    CAS  PubMed  Google Scholar 

  • Magee LA, Ornstein MP, Von Dadelszen P (1999) Fortnightly review: management of hypertension in pregnancy. BMJ 318:1332–1366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Magee LA, von Dadelszen P, Bohun CM et al (2003) Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study. J Obstet Gynaecol Can 2:372–382

    Article  Google Scholar 

  • Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, on behalf of the Canadian hypetensive disorders of pregnancy (HDP) working group (2014) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 4:105–145

    PubMed  Google Scholar 

  • Magee LA, von Dadelszen P, Rey E et al (2015) Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 372(5):407–417

    Article  CAS  PubMed  Google Scholar 

  • Malin G, Bell SC, Waugh JJS (2007) Random albumin/creatinine ratio for quantification of proteinuria in manifest preeclampsia. Br J Obstet Gynaecol 114:118–119

    Article  CAS  Google Scholar 

  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219

    Article  PubMed  Google Scholar 

  • Martin JN Jr (2013) Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia). Int J Gynecol Obstet 121:202–207

    Article  Google Scholar 

  • Martin JN, Files JC, Blake PG, Norman PH, Martin RW, Hess WL, Morrison JC, Wiser WL (1990) Plasma exchange for preeclampsia I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol 162:126–137

    Article  PubMed  Google Scholar 

  • Martin JN Jr, Rinehart B, May WL et al (1999) The spectrum of severe preeclampsia: comparative analysis by HELLP syndrome classification. Am J Obstet Gynecol 180:1373–1384

    Article  PubMed  Google Scholar 

  • Martin JN, Rose CH, Briery CM (2006) Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 195:914–934

    Article  CAS  PubMed  Google Scholar 

  • Matchaba P, Moodley J (2004) Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev CD 002076

    Google Scholar 

  • Matsuo K, Kooshesh S, Dinc M, Sun CCJS, Kimura T, Baschat A (2007) Late postpartum eclampsia: report of two cases managed by uterine curettage and review of the literature. Am J Perinatol 24:257–266

    Article  PubMed  Google Scholar 

  • McCarthy FP, Drewlo S, English FA, Kingdom J, Johns EJ, Walsh SK, Kenny LC (2011a) Evidence implicating peroxisome proliferator-activated receptor- γ in the pathogenesis of preeclampsia. Hypertension 58:882–887

    Article  CAS  PubMed  Google Scholar 

  • McCarthy FP, Drewlo S, Kingdom J, Johns EJ, Walsh SK, Kenny LC (2011b) Peroxisome proliferator-activated receptor- γ as a potential therapeutic target in the treatment of preeclampsia. Hypertension 58:280–286

    Article  CAS  PubMed  Google Scholar 

  • McGregor JA, Allen KG, Harris MA, Reese M, Wheeler M, French JI et al (2001) The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcome. Obstet Gynecol Surv 56(5 Suppl 1):S1–S13

    Article  CAS  PubMed  Google Scholar 

  • McMaster MT, Zhou J, Fisher SJ (2004) Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 24:540–547

    Article  PubMed  Google Scholar 

  • Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, Riet tre G et al (2008) Methods of prediction and prevention of pre-eclmapsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 12(6):iii–iv; 1–270

    Article  CAS  Google Scholar 

  • Mello G, Parretti E, Fatini C, Riviello C, Genuini F et al (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45:86–91

    Article  CAS  PubMed  Google Scholar 

  • Merchant SH, Mathew P, Vanderjagt TJ et al (2004) Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol 103:1055–1058

    Article  PubMed  Google Scholar 

  • Michael CA (1979) Use of labetalol in the treatment of severe hypertension during pregnancy. Br J Clin Pharmacol 8(Suppl 2):211–215

    Article  Google Scholar 

  • Middeldorp S (2007) Thrombophilia and pregnancy, complications: cause or association? J Thromb Haemost 5:276–282

    Article  CAS  PubMed  Google Scholar 

  • Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J, Romney SL (1994) Preeclampsia and antioxidant nutritients: decreased plasma levels of reduced ascorbic acid, α-tocopherol, and β-carotene in women with preeclampsia. Am J Obstet Gynecol 171:150–157

    Article  CAS  PubMed  Google Scholar 

  • Minakami H, Morikawa M, Yamada T, Yamada T, Akaishi R, Nishida R (2014) Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis, elevated liver enzymes and low platelet counts. J Obstet Gynaecol Res 40(3):641–649

    Article  PubMed  Google Scholar 

  • Miyakis S, Lockshin MD, Atsumi T, Branch DW et al (2006) International consensus statement on a update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306

    Article  CAS  PubMed  Google Scholar 

  • Montan S, Marzal K, Ingemarsson, NO S (1992) Randomised controlled trial of atenolol and pindolol in human pregancy: effects on fetal hemodynamics. BMJ 304:946–949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moran P, Lindheimer MD, Davison JM (2004) The renal response to preeclampsia. Semin Nephrol 24:588–595

    Article  PubMed  Google Scholar 

  • Morris MC, Twickler DM, Hatab MR et al (1997) Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 89:561–568

    Article  Google Scholar 

  • Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD (2012) Diagnostic accuracy of spot urinary protein and albumin to creatinin ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ 9(345):e4342

    Article  CAS  Google Scholar 

  • Mushambi MC, Halligan AW, Williamson K (1996) Recent developments in the pathophysiology and management of pre-eclampsia. Br J Anaesth 76:133–148

    Article  CAS  PubMed  Google Scholar 

  • National Institutes of Health (2000) Working group report on high blood pressure in pregnancy. National Institutes of Health, Washington DC

    Google Scholar 

  • Ness RB, Roberts JM (1996) Heterogenous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365–1370

    Article  CAS  PubMed  Google Scholar 

  • NICE (2011) NICE clinical guideline 107. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. Issued: Aug 2010, last modified: Jan 2011. www.guidance.nice.org.uk/cg107

  • North R, Ferrier C, Long D, Townend K, Kinkaid-Smith P (1994) Prevention of preeclampsia with prophylactic heparin and anti-platelet agents in women with underlying renal disease. Hypertens Pregnancy 13:135–144

    Article  Google Scholar 

  • O´Brian E, Asmar R, Beilin L et al (2005) Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697–701

    Article  Google Scholar 

  • O’Brien JM, Barton JR (2005) Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 46:460–477

    Article  Google Scholar 

  • Odegard RA, Vatten LJ, Nilsen ST et al (2000) Preeclampsia and fetal growth. Obstet Gynecol 96:950–955

    CAS  PubMed  Google Scholar 

  • Odendaal HJ, Pattison RC, Bam R, Grove D, Kotze TJW (1990) Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks gestation: a randomized controlled trial. Obstet Gynecol 76:1070–1076

    CAS  PubMed  Google Scholar 

  • Olson S, Sacher NJ, Tabor A, Weber T, Walker JJ, Gland C (2000) Randomised clinical trials of fish oil supplementation in high-risk pregnancies. Br J Obstet Gynaecol 107:382–395

    Article  Google Scholar 

  • Ounsted M (1988) The children of women who had hypertension during pregnancy. In: Rubin PC (Hrsg) Hypertension in pregnancy, Bd 10. Elsevier, Amsterdam, S 341–362

    Google Scholar 

  • Papafragkakis H, Singhal S, Anand S (2013) Acute fatty liver in pregnancy. South Med J 106(10):588–593

    Article  CAS  PubMed  Google Scholar 

  • Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS (1993) Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 100:909–913

    Article  CAS  PubMed  Google Scholar 

  • Podymow T, August P (2008) Update on the use of antihypertensive drugs in pregnancy. Hypertension 51:960–969

    Article  CAS  PubMed  Google Scholar 

  • Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH (2009) First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 53:812–818

    Article  CAS  PubMed  Google Scholar 

  • Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH (2006) Vitamins in Pre-eclampsia (VIP) trial consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367:1145–1154

    Article  CAS  PubMed  Google Scholar 

  • Raio L, Ghezzi F, Cromi A, Nelle M, Dürig P, Schneider H (2004) Sonographic jelly-like appearance of the placenta: a strong predictor of adverse pregnancy outcome. Prenat Diagn 24:182–188

    Article  PubMed  Google Scholar 

  • Ramma W, Ahmed A (2011) Is inflammation the cause of preeclampsia? Biochem Soc Trans 39:1619–1627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rasmussen S, Irgens LM (2003) Fetal growth and body proportion in preeclampsia. Obstet Gynecol 101:575–583

    PubMed  Google Scholar 

  • Ray JG, Vermeulen MJ, Schull MJ, Redlmeier DA (2005) Cardiovascular health afte matenal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366:1797–1803

    Article  PubMed  Google Scholar 

  • Redman CWG (1991) Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 17:149–154

    Article  CAS  PubMed  Google Scholar 

  • Redman CWG (1995) Hypertension in pregnancy. In: De Swiet M (Hrsg) Medical disorders in obstetric practice. Blackwell, Oxford, S 182–225

    Google Scholar 

  • Redman CWG, Ounsted MK (1982) Safety for the child of drug treatment for hypertension in pregnancy. Lancet 1:1237

    Article  CAS  PubMed  Google Scholar 

  • Redman CWG, Sargent IL (2003) Pre-eclampsia, the placenta and the maternal systemic inflammatory response: a review. Placenta 24(Suppl A):S21–S27

    Article  PubMed  Google Scholar 

  • Redman CWG, Sargent IL (2009) Placental stress and preeclampsia: a revised view. Placenta 30(Suppl A):S38–S42, Trophoblast Research 23

    Article  PubMed  CAS  Google Scholar 

  • Redman CW, Sargent IL (2010) Immunology of preeclampsia. Am J Reprod Immunol 63:534–543

    Article  CAS  PubMed  Google Scholar 

  • Redman CWG, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180:499–506

    Article  CAS  PubMed  Google Scholar 

  • Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), ESC Committee for Practice Guidelines et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197

    Article  PubMed  Google Scholar 

  • Rey E, Couturier A (1994) The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 171:410–416

    Article  CAS  PubMed  Google Scholar 

  • Rey E, Garneau P, David M, Gauthier R, Leduc N et al (2009) Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 7:58–64

    Article  CAS  PubMed  Google Scholar 

  • Rimoldi FS, Scherrer U, Messerli FM. (2013) Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 23. doi:10.1093

    Google Scholar 

  • Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E (2013) Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta – analysis. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol 41(5):491–499

    Article  CAS  Google Scholar 

  • Roberts JM, Hubel CA (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354:788–789

    Article  CAS  PubMed  Google Scholar 

  • Robinson M (1958) Salt in pregnancy. Lancet 1:178–181

    Article  CAS  PubMed  Google Scholar 

  • Rodger MA, Paidas M, McLintock C et al (2008) Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 112(2Pt1):320–324

    Article  PubMed  Google Scholar 

  • Rogue H, Paidas MJ, Funai EF et al (2004) Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 91:290–295

    Google Scholar 

  • Rolfes D, Ishak K (1985) Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. Hepatology 5:1149–1158

    Article  CAS  PubMed  Google Scholar 

  • Ruffati A, Dalla Barba B, Del Ross T et al (1998) Outcome of fifty-five newborns of antiphospholipid antibody-postive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 16:605–610

    Google Scholar 

  • Rumbold A, Duley L, Crowther CA, Haslam RR (2008) Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 23(1), CD004227

    Google Scholar 

  • Sattar N, Greer IA (2002) Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med J 325:157–160

    Article  Google Scholar 

  • Saudan P, Brown MA, Buddle ML, Jones M (1998) Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 105:1177–1184

    Article  CAS  PubMed  Google Scholar 

  • Schlenzing C, Maurer S, Goppelt M, Ulm K, Kolben M (2000) Postpartum curettage in patients with HELLP-Syndrome does not result in accelerated recovery. Eur J Obstet Gynecol Biol Reprod 91:25–28

    Article  Google Scholar 

  • Sergio F, Maria Clara D, Gabriella F et al (2006) Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 25:115–162

    Article  PubMed  CAS  Google Scholar 

  • Shekhar S, Sharma C, Thakur S, Verma S (2013) Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstet Gynecol 122(5):1057–1063

    Article  CAS  PubMed  Google Scholar 

  • Shojaati K, Causevic M, Kadereit B et al (2004) Evidence for compromised aldosterone synthase enzyme activity in preeclampsia. Kidney Int 66:2322–2328

    Article  CAS  PubMed  Google Scholar 

  • Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 335:275–265

    Article  Google Scholar 

  • Sibai BM (2002) Chronic hypertension in pregnancy. Obstet Gynecol 100:369–377

    Article  PubMed  Google Scholar 

  • Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181–192

    PubMed  Google Scholar 

  • Sibai BM (2004a) Diagnosis, controversies and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103:981–991

    Article  PubMed  Google Scholar 

  • Sibai BM (2004b) Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 190:1520–1526

    Article  CAS  PubMed  Google Scholar 

  • Sibai BM (2005) Diagnosis, prevention and management of preeclampsia. Obstet Gynecol 105:402–410

    Article  PubMed  Google Scholar 

  • Sibai BM (2007) Imitators of severe preecplampsia. Obstet Gynecol 109:956–966

    Article  PubMed  Google Scholar 

  • Sibai BM, Stella CL (2009) Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 200:481.e1–481.e7

    Article  Google Scholar 

  • Sibai BM, Abdella TN, Spinnato JA, Anderson GD (1986) Eclampsia V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol 154:581–586

    Article  CAS  PubMed  Google Scholar 

  • Sibai BM, Mercer B, Sarinoglu C (1991) Severe preeclampsia in the second trimester: recurrence risk and long term prognosis. Am J Obstet Gynecol 165:1408–1412

    Article  CAS  PubMed  Google Scholar 

  • Sibai BM, Barton JR, Akl S et al (1992) A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 167:879–884

    Article  CAS  PubMed  Google Scholar 

  • Sibai BM, Ramadan MK, Usta I et al (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169:1000–1006

    Article  CAS  PubMed  Google Scholar 

  • Sibai BM, Mercer BM, Schiff E, Friedman SA (1994) Aggressive versus expectant management of severe preeclampsia at 28–32 weeks gestation. Am J Obstet Gynecol 171:818–822

    Article  CAS  PubMed  Google Scholar 

  • Sibiude J, Guibourdenche J, Dionne MD, Le Ray C, Anselem O et al (2012) Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One 7(11):e50208

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Simon J, Gray A, Duley L, Magpie Trial Collaborative Group (2006) Cost-effectiveness of phrophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial. BJOG 113(2):144–151

    Article  PubMed  Google Scholar 

  • Smulian JC, Anath CV, Vinzileos AM, Knuppel RA (2002) Fetal deaths in the United States. Influence of high-risk conditions and implications for management. Obstet Gynecol 100:1183–1189

    PubMed  Google Scholar 

  • Smith GC (2001) Life-table analysis of the rate of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol 184:489–496

    Article  CAS  PubMed  Google Scholar 

  • Smith P, Anthony J, Johanson R (2000) Nifedipine in pregnancy. BJOG 107:299–307

    Article  CAS  PubMed  Google Scholar 

  • Smith NA, Lyons JG, McElrath TF (2010) Protein:creatinine ratio in uncomplicated twin pregnancy. Am J Obstet Gynecol 203(381):e1–e4

    Google Scholar 

  • Snyder SW, Cardwell MS (1989) Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 161:35–36

    Article  CAS  PubMed  Google Scholar 

  • Spinnato JA II, Freire S, Pinto e Silav JL, Cunha Rudge MV, Martins-Costa S, Koch MA et al (2007) Antioxidant therapy to prevent preeclampsia: a randomised controlled trial. Obstet Gynecol 110:1311–1318

    Article  CAS  PubMed  Google Scholar 

  • Steiner M (1989) Aktuelle Bilanz der mütterlichen Mortalität. In: Hillemanns HG, Schillinger H (Hrsg) Das Restrisiko gegenwärtiger Geburtshilfe. Springer, Berlin, S 17–S 23

    Chapter  Google Scholar 

  • Stepan H, Jank A (2009) Angiogene Faktoren und ihre Rolle in der Entstehung und Vorhersage der Präeklampsie. Z Geburtshilfe Neonatol 213(3):101–105

    Article  CAS  PubMed  Google Scholar 

  • Stepan H, Geipel A, Schwarz F, Krämer T, Wessel N, Faber R (2008) Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 198(2):175.e1–175 e6

    Article  CAS  Google Scholar 

  • Stern C, Trapp EM, Mautner E, Lang U, Vervar-Zivkovic M (2013) The impact of severe preeclampsia on maternal quality of life. Qual Life Res. doi:10.1007/s11136-013-0525-3

    PubMed  Google Scholar 

  • Subtil D, Goeusse P, Houfflein-Deborge V et al (2003a) Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women, pt 2. BJOG 110:485–491

    CAS  PubMed  Google Scholar 

  • Subtil D, Goeusse P, Puech F et al (2003b) Aspririn (100 mg) used for prevention of preeclampsia in nulliparous women, pt 1. BJOG 110:475–484

    CAS  PubMed  Google Scholar 

  • Talledo OE (1966) Renin-angiotensin system in normal and toxemic pregnancies. I. Angiotensininfusion test. Am J Obstet Gynecol 96:141–143

    CAS  PubMed  Google Scholar 

  • Thadhani R, Kistner T, Hagman H, Bossung V, Noack S, Schaarschmidt W, Jank A, Kribs A, Cornely OA, Kreyssig C, Hemphill L, Rigby AC, Khedkar S, Lindner TH, Mallmann P, Stepan H, Karumanchi SA, Benzing T (2011) Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124:940–950

    Article  CAS  PubMed  Google Scholar 

  • Thangaratinam S, Ismail KMK, Shap S, Coomarasany A, Khan KS (2006) Accuracy of serum uric acid in predicting complications of preeclampsia: a systemic review. Br J Obstet Gynaecol 113:369–378

    Article  CAS  Google Scholar 

  • Thangaratinam S, Coomarasany A, O’Mahony F, Sharp S et al (2009) Estimation of proteinuria as a predictor of complications of pre-eclmapisa: a systematic review. BMC Med 7:1–9

    Article  CAS  Google Scholar 

  • The Magpie Trial (2002) Do women with preeclampsia, and their babies, benefit from magnesium sulfate? A randomised placebo-controlled trial. Lancet 359:1877–1890

    Article  Google Scholar 

  • Towers CV, Piron RA, Nageotte MP et al (1993) Cocain intoxication presenting as preeclampsia and eclampsia. Obstet Gynecol 81:545–547

    CAS  PubMed  Google Scholar 

  • Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM (2013) The definition of severe early –onset preeclampsia. Statements from the international society fort he study of hypertension in pregnancy (ISSHP). Pregnancy Hypertens 3:44–47

    PubMed  Google Scholar 

  • Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA (2014) The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Hypertens Pregnancy 4:97–104

    CAS  Google Scholar 

  • Triche EW, Uzun A, DeWan AT, Kurihara I, Liu J, Occhiogrosso R, Shen B, Parker J, Padbury JF (2014) Bioinformatic approach to the genetics of preeclampsia. Obstet Gynecol 123(6):1155–1161

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tuffnell DJ, Lilford RJ, Buchanan PC (1992) Randomised controlled trial of daycare for hypertension in pregnancy. Lancet 339:224–227

    Article  CAS  PubMed  Google Scholar 

  • Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russel IF, Walker JJ (2005) Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. Br J Obstet Gynaecol 112:875–880

    Article  CAS  Google Scholar 

  • Uzan S, Beaufils M, Breart G, Bazic B, Capitant C, Paris J (1991) Prevention of fetal growth retardation with low dose aspirin: findings of the EPREDAL trial. Lancet 337:1427–1431

    Article  CAS  PubMed  Google Scholar 

  • Van Wijk MJ, Nieuwland R, Boer K et al (2002) Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol 187:450–456

    Article  Google Scholar 

  • Varner M, Rinderknecht NK (1980) Acute fatty metamorphosis of pregnancy. A maternal mortality and literature review. J Reprod Med 24(4):177–180

    CAS  PubMed  Google Scholar 

  • Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642–649

    Article  CAS  PubMed  Google Scholar 

  • Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H (2010) An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 202(2):161.e1–161.e11

    Article  CAS  Google Scholar 

  • Vetter K, Kilavuz Ö (1999) Dopplersonografie und Präeklampsie. Gynakologe 10:761–767

    Google Scholar 

  • Vikse BE, Irgens LM, Leivestad T, Skjaerven RS, Iversen BM (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359:800–809

    Article  CAS  PubMed  Google Scholar 

  • Villar J, Abalos B, Nardin JM et al (2004) Strategies to prevent and treat preeclampsia: evidence fromrandomized controlled trials. Semin Nephrol 24:607–615

    Article  PubMed  Google Scholar 

  • Villar J, Purvar M, Merialdi M, Zavaleta N, Tien NN, Anthony J (2007) WHO randomised trial of vitamine C & E supplementation among women at high risk for preeclampsia and nutritional deficiency. Am J Obstet Gynecol 197:S4

    Article  Google Scholar 

  • Vink GJ, Moodley J (1982) The effect of low-dose dihydralazine on the fetus in the emergency treatment of hypertension in pregnancy. S Afr Med J 62:475–477

    CAS  PubMed  Google Scholar 

  • Visser W, Wallenburg HCS (1995a) Temporising management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 102:111–117

    Article  CAS  PubMed  Google Scholar 

  • Visser W, Wallenburg ACS (1995b) Maternal and perinatal outcome of temporizing menagement in 254 consecutive patients with severe preeclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 63:147–153

    Article  CAS  PubMed  Google Scholar 

  • von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a metaanalysis. Lancet 355:87–92

    Article  Google Scholar 

  • Waismann GD, Mayorga L, Camer MI, Vignolo CA, Martinotti A (1988) Magnesium plus nifedipin: potentiation of hypotensive effects in preeclampsia? Am J Obstet Gynecol 159:308–309

    Article  Google Scholar 

  • Waugh JJ, Clark TJ, Divakaran TG et al (2004) Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy. Obstet Gynecol 103:769–777

    Article  PubMed  Google Scholar 

  • Wei Q, Zhang L, Liu X (2010) Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases. J Obstet Gynaecol Res 36(4):751–756

    Article  PubMed  Google Scholar 

  • Welsch H, Krone HA (1994) Mütterliche Mortalität und HELLP-Syndrom in Bayern 1982–1992. Zentralbl Gynakol 116:202–206

    CAS  PubMed  Google Scholar 

  • Wikström AK, Haglund B, Olovsson M, Lindenberg SN (2005) The risk of maternal heart disease after gestational hypertensive disease. Br J Obstet Gynaecol 112:1486–1491

    Article  Google Scholar 

  • Williams MA, Zingheim RW, Kind IB, Zebelman AM (1995) Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 6:232–237

    Article  CAS  PubMed  Google Scholar 

  • Wilson WA, Gharavi AE, Koike T et al (1999) International Consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311

    Article  CAS  PubMed  Google Scholar 

  • Wilton A, de Greef A, Shennan A (2007) Rapid assessment of blood pressure in the obstetric day unit using Microlife MaM technology. Hypertens Pregnancy 26:31–37

    Article  PubMed  Google Scholar 

  • Xuong XY, Wang FL, Davidge ST et al (2000) Maternal smoking and preeclampsia. J Reprod Med 45:727

    Google Scholar 

  • Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG (2004) Cerebral infarction in eclampsia. Am J Obstet Gynecol 190:714–720

    Article  PubMed  Google Scholar 

  • Zhang J, Meikle S, Trumble A (2003) Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 22(2):203–212

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Frauenheilkunde, Inselspital, Effingerstr. 102, 3010, Bern, Schweiz

    Luigi Raio & Henning Schneider

  2. Universitätsklinik für Frauenheilkunde, Inselspital, 3010, Bern, Schweiz

    Marc Baumann

Authors
  1. Luigi Raio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henning Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luigi Raio .

Editor information

Editors and Affiliations

  1. Frauenklinik, Universitätsklinikum, Bern, Switzerland

    Henning Schneider

  2. Frauenklinik, Medizinische Universität Wien, Wien, Austria

    Peter Husslein

  3. Frauenklinik u. Poliklinik, TU, Klinikum Rechts d. Isar, München, Germany

    Karl-Theo M. Schneider

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Raio, L., Baumann, M., Schneider, H. (2016). Hypertensive Schwangerschaftserkrankungen. In: Schneider, H., Husslein, P., Schneider, KT. (eds) Die Geburtshilfe. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45064-2_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45064-2_22

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45063-5

  • Online ISBN: 978-3-662-45064-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation